AEM vs PAAS

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

PAAS exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet (Debt/Equity 0.12). While the current price of $52.29 is well above the defensive Graham Number ($30.91), it remains significantly discounted relative to its growth-based intrinsic value of $75.52 and analyst targets. The company is experiencing explosive YoY earnings growth (258.6%) and maintains superior margins compared to sector averages. Despite a bearish short-term technical trend, the fundamental growth trajectory and low leverage provide a strong bullish case.